These earlier analyses are complicated by a variety of therapeutic interventions (insulin, metformin, oral hypoglycemics, angiotensin receptor antagonists, statins, etc.)commonly employed in diabetic therapy that also may influence the incidence of cancer [3], [4], [5], [6]. Here, INS is linked to cancer.